Figure 1.

(A-O) ¹⁸F-FDG PET/CT scans. Equivalent full body images on each row are shown. To indicate the changes in ¹⁸F-FDG uptake, areas of lesions (red intersections) with increased ¹⁸F-FDG uptake are displayed. A baseline ¹⁸F-FDG PET/CT scan prior to the start of chemotherapy identified increased ¹⁸F-FDG uptake in multiple bones (A, lumbar; D, right iliac crest; M, colored full body image), in (G) the right hilum and in (J) the right upper lung. Following chemotherapy treatments, ¹⁸F-FDG PET/CT scans identified gradually reduced ¹⁸F-FDG uptake in all the above lesions after 3 months (B, E, H, K and N) and 8 months (C, F, I, L and O) of chemotherapy treatments. ¹⁸F-FDG PET/CT, F-18 fluorodeoxy glucose positron electron tomography/computed tomography.